Clinical studies with matrix metalloproteinase inhibitors.
about
Metalloproteinases: role in breast carcinogenesis, invasion and metastasisMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisDrug development against metastasis-related genes and their pathways: A rationale for cancer therapyPyrone-Based Inhibitors of Metalloproteinase Types 2 and 3 May Work as Conformation-Selective InhibitorsPOVME: an algorithm for measuring binding-pocket volumes.Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.Matrix metalloproteinase biology applied to vitreoretinal disorders.Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureStroma targeting nuclear imaging and radiopharmaceuticals.Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.Synthesis and evaluation of novel heterocyclic MMP inhibitors.Drug resistance associated with antiangiogenesis therapy.Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.
P2860
Q24803225-A07017AD-B5F2-4D35-8BC4-BF33348EA7DAQ28140740-E2C76A1A-9F22-49A2-875A-D0E27CEFC3F3Q29010479-6C332C86-AACF-437A-9939-9BC119AADB17Q30039761-8225E372-E04C-4788-9284-2E74226B9AADQ30499011-7FC34B27-A939-4D07-8570-E261098A6CC2Q33754764-84B19917-6D51-4110-AEE2-063CBD6E8B15Q33933063-5ADF4242-44D2-4123-8EC0-69F400CDB8BBQ33947243-D162F73F-D759-444A-9FF2-3CA6DA38574AQ34175711-EBC22820-1A68-4388-8791-1A9235F09170Q35995215-CFEF3789-6CF8-43BF-8B57-946F9795A123Q35999606-9FFD2439-A587-4399-A27D-BB711FA76FE9Q36068428-8929CC4C-AE3B-42DC-B75B-D7FCB0892CDCQ36953454-637B2EE0-24B1-44F1-8542-16D58F75794EQ37518288-27599675-F4DF-4D4B-B336-C3E371A0CADEQ38264461-4F6C12DC-C862-4950-9ED7-B5AFC554E831
P2860
Clinical studies with matrix metalloproteinase inhibitors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clinical studies with matrix metalloproteinase inhibitors.
@ast
Clinical studies with matrix metalloproteinase inhibitors.
@en
Clinical studies with matrix metalloproteinase inhibitors.
@nl
type
label
Clinical studies with matrix metalloproteinase inhibitors.
@ast
Clinical studies with matrix metalloproteinase inhibitors.
@en
Clinical studies with matrix metalloproteinase inhibitors.
@nl
prefLabel
Clinical studies with matrix metalloproteinase inhibitors.
@ast
Clinical studies with matrix metalloproteinase inhibitors.
@en
Clinical studies with matrix metalloproteinase inhibitors.
@nl
P1476
Clinical studies with matrix metalloproteinase inhibitors.
@en
P2093
P304
P577
1999-01-01T00:00:00Z